We are live on ! Find out more
GBNY

Generations Bancorp NY, Inc. Common Stock

Delisted

GBNY was delisted on the 4th of October, 2024.

12 hedge funds and large institutions have $10.1M invested in Generations Bancorp NY, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $8.95M → $10.1M (+$1.18M)

0% more funds holding

Funds holding: 1212 (0)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
2
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

GBNY Hedge Fund Activity: Q3 2021 in Review

12 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Generations Bancorp NY, Inc. Common Stock (GBNY) for Q3 2021, worth a combined $10.1M — up 13% from $8.95M a quarter earlier.

Fund positioning in GBNY was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $2.25K. The largest seller was Tower Research Capital (TRC), cutting an estimated $13.4K.

  • 12 institutional investors held Generations Bancorp NY, Inc. Common Stock (GBNY) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $10.1M of Generations Bancorp NY, Inc. Common Stock stock for Q3 2021, up 13% quarter-over-quarter.
  • 0 funds opened new Generations Bancorp NY, Inc. Common Stock positions in Q3 2021 and 0 closed out.
  • The largest Generations Bancorp NY, Inc. Common Stock buyer in Q3 2021 was AllianceBernstein, an estimated $2.25K added.
  • The largest Generations Bancorp NY, Inc. Common Stock seller in Q3 2021 was Tower Research Capital (TRC), an estimated $13.4K sold.

Based on aggregated 13F filings for Q3 2021.